Patricia L Morris

Array ( [id] => 6597102 [patent_doc_number] => 20100048640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'HYDRAZIDE COMPOUND AND HARMFUL ARTHROPOD-CONTROLLING AGENT CONTAINING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/593536 [patent_app_country] => US [patent_app_date] => 2008-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41837 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048640.pdf [firstpage_image] =>[orig_patent_app_number] => 12593536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6323278 [patent_doc_number] => 20100113794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'METHOD FOR PRODUCING AMIDE COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/595487 [patent_app_country] => US [patent_app_date] => 2008-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18170 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113794.pdf [firstpage_image] =>[orig_patent_app_number] => 12595487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685275 [patent_doc_number] => 20100120866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'PROCESS FOR PRODUCING AMIDE COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/595471 [patent_app_country] => US [patent_app_date] => 2008-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20388 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120866.pdf [firstpage_image] =>[orig_patent_app_number] => 12595471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6591334 [patent_doc_number] => 20100130509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'NOVEL ANTIBIOTICS' [patent_app_type] => utility [patent_app_number] => 12/594014 [patent_app_country] => US [patent_app_date] => 2008-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4986 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130509.pdf [firstpage_image] =>[orig_patent_app_number] => 12594014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4886982 [patent_doc_number] => 20080261314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'FLUORESCENT PROBE FOR ZINC' [patent_app_type] => utility [patent_app_number] => 12/058289 [patent_app_country] => US [patent_app_date] => 2008-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7150 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20080261314.pdf [firstpage_image] =>[orig_patent_app_number] => 12058289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8858808 [patent_doc_number] => 08461343 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-11 [patent_title] => 'Synthesis of thiohydantoins' [patent_app_type] => utility [patent_app_number] => 12/450423 [patent_app_country] => US [patent_app_date] => 2008-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12083 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12450423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9620966 [patent_doc_number] => 08791140 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-29 [patent_title] => 'Crystalline forms of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-E-[2-(pyridin-2-yl)ethenyondazole suitable for the treatment of abnormal cell growth in mammals' [patent_app_type] => utility [patent_app_number] => 12/594575 [patent_app_country] => US [patent_app_date] => 2008-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18268 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12594575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4619263 [patent_doc_number] => 07998983 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'Substituted isoxazoles as fungicides' [patent_app_type] => utility [patent_app_number] => 12/041058 [patent_app_country] => US [patent_app_date] => 2008-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11692 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/998/07998983.pdf [firstpage_image] =>[orig_patent_app_number] => 12041058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4445442 [patent_doc_number] => 07863454 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-04 [patent_title] => '3-substituted-6-aryl pyridines' [patent_app_type] => utility [patent_app_number] => 12/041038 [patent_app_country] => US [patent_app_date] => 2008-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 86710 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/863/07863454.pdf [firstpage_image] =>[orig_patent_app_number] => 12041038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6604399 [patent_doc_number] => 20100063056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'BIPYRIDINE CARBOXAMIDE OREXIN RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/528142 [patent_app_country] => US [patent_app_date] => 2008-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13036 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063056.pdf [firstpage_image] =>[orig_patent_app_number] => 12528142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9166782 [patent_doc_number] => 08592460 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-26 [patent_title] => 'Amino-pyridine derivatives as S1P1 /EDG1 receptor agonists' [patent_app_type] => utility [patent_app_number] => 12/531374 [patent_app_country] => US [patent_app_date] => 2008-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36017 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12531374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6493397 [patent_doc_number] => 20100209418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'Solid Forms of a Raf Kinase Inhibitor' [patent_app_type] => utility [patent_app_number] => 12/529258 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 22254 [patent_no_of_claims] => 155 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20100209418.pdf [firstpage_image] =>[orig_patent_app_number] => 12529258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8375369 [patent_doc_number] => 08258161 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-04 [patent_title] => 'Crystalline salt form of an antidiabetic compound' [patent_app_type] => utility [patent_app_number] => 12/529202 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6385 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12529202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4887710 [patent_doc_number] => 20080262042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Pyrrole compounds' [patent_app_type] => utility [patent_app_number] => 12/072421 [patent_app_country] => US [patent_app_date] => 2008-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 77318 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20080262042.pdf [firstpage_image] =>[orig_patent_app_number] => 12072421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6321521 [patent_doc_number] => 20100113526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'Process for the Preparation of Esomeprazole Magnesium Dihydrate' [patent_app_type] => utility [patent_app_number] => 12/527967 [patent_app_country] => US [patent_app_date] => 2008-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6310 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113526.pdf [firstpage_image] =>[orig_patent_app_number] => 12527967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6619067 [patent_doc_number] => 20100099882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'PROCESS FOR THE PREPARATION OF A BENZIMIDAZOLE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 12/525867 [patent_app_country] => US [patent_app_date] => 2008-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4110 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099882.pdf [firstpage_image] =>[orig_patent_app_number] => 12525867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6637805 [patent_doc_number] => 20100035934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'PYRIDINYL-PYRAZOLE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/525512 [patent_app_country] => US [patent_app_date] => 2008-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9739 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20100035934.pdf [firstpage_image] =>[orig_patent_app_number] => 12525512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 24042 [patent_doc_number] => 07795276 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'Imiadazo[4,5-c] pyridine compound and method of antiviral treatment' [patent_app_type] => utility [patent_app_number] => 12/022557 [patent_app_country] => US [patent_app_date] => 2008-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4275 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/795/07795276.pdf [firstpage_image] =>[orig_patent_app_number] => 12022557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4515706 [patent_doc_number] => 07932273 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-26 [patent_title] => '3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl) phenylamino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionic acid ethylester methansulfonate and its use as a medicament' [patent_app_type] => utility [patent_app_number] => 12/022655 [patent_app_country] => US [patent_app_date] => 2008-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 2 [patent_no_of_words] => 3837 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/932/07932273.pdf [firstpage_image] =>[orig_patent_app_number] => 12022655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4823386 [patent_doc_number] => 20080227821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS ANTI-MITOTIC TUBULIN POLYMERIZATION INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/021535 [patent_app_country] => US [patent_app_date] => 2008-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11498 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227821.pdf [firstpage_image] =>[orig_patent_app_number] => 12021535 [rel_patent_id] =>[rel_patent_doc_number] =>)